Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ipilimumab-associated Sweet syndrome in a melanoma patient.

× No keyword cloud information.

7 in total

Review 1. Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.

Authors: Shannon K Quirk; Anna K Shure; Devendra K Agrawal
Journal: Transl Res Date: 2015-06-11 Impact factor: 7.012

Review 2. Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.

Authors: Samantha R Ellis; Aren T Vierra; Jillian W Millsop; Mario E Lacouture; Maija Kiuru
Journal: J Am Acad Dermatol Date: 2020-04-29 Impact factor: 11.527

Review 3. Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article.

Authors: Chieh-Hsun Chen; Hsin-Su Yu; Sebastian Yu
Journal: Curr Oncol Date: 2022-04-18 Impact factor: 3.109

4. First case of Merkel cell carcinoma in a young patient with Sweet syndrome.

Authors: Albert Liao; Hasan Danish; Benjamin Stoff; Mohammad K Khan
Journal: Adv Radiat Oncol Date: 2016-05-07

Review 5. Insights Into the Pathogenesis of Sweet's Syndrome.

Authors: Michael S Heath; Alex G Ortega-Loayza
Journal: Front Immunol Date: 2019-03-12 Impact factor: 7.561

6. "Skin rashes" and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management.

Authors: Pietro Sollena; Simone Cappilli; Francesco Federico; Giovanni Schinzari; Giampaolo Tortora; Ketty Peris
Journal: Hum Vaccin Immunother Date: 2021-03-24 Impact factor: 4.526

7. Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.

Authors: Isabella Pospischil; Wolfram Hoetzenecker
Journal: J Dtsch Dermatol Ges Date: 2021-11 Impact factor: 5.231

7 in total